483 NPS Pharmaceuticals Dec 2012

483 NPS Pharmaceuticals Dec 2012

Christina Maurino FDA$119.00 - Available Now

FDA investigators audited the NPS Pharmaceuticals - Bedminster, NJ, United States facility and issued 4 inspectional observations (via FDA 483) on 04 Dec 2012.

Product details

  • Category: Human Drugs
  • Number of Observations: 4
  • Inspection end: 04 Dec 2012
  • Location: Bedminster, United States
  • FEI: 3009694025
Add To Cart